Pembrolizumab for melanoma- safety profile and future trends

被引:7
|
作者
Daud, Adil [1 ]
Nandoskar, Prachi [1 ]
机构
[1] UCSF Helen Diller Comprehens Canc Ctr, Melanoma Clin Res, Dept Med Hematol Oncol, 1600 Divisadero St,Box 1297, San Francisco, CA 94115 USA
关键词
Melanoma; pembrolizumab; safety; cancer immunotherapy; PD-1; SOLID TUMORS; PATIENTS PTS; IPILIMUMAB; MK-3475; CHEMOTHERAPY; ASSOCIATION; KEYNOTE-002; THERAPY; CANCER; PEMBRO;
D O I
10.1080/14740338.2016.1175430
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:727 / 729
页数:3
相关论文
共 50 条
  • [1] Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety
    Nebhan, Caroline A.
    Johnson, Douglas B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (06) : 583 - 590
  • [2] Pembrolizumab for the treatment of melanoma
    Kumar, Sanjeev Srinivas
    McNeil, Catriona Mairi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (05) : 515 - 527
  • [3] Safety of pembrolizumab for the treatment of melanoma
    Martin-Liberal, Juan
    Kordbacheh, Tiana
    Larkin, James
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (06) : 957 - 964
  • [4] Safety of pembrolizumab for resected stage III melanoma
    Pham, F.
    Dalle, S.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (10) : 1221 - 1227
  • [5] The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis
    Puri, Akshjot
    Homsi, Jade
    MELANOMA RESEARCH, 2017, 27 (05) : 519 - 523
  • [6] Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients
    Schaefer, Anne
    Sachpekidis, Christos
    Diella, Francesca
    Doerks, Anja
    Kratz, Anne-Sophie
    Meisel, Christian
    Jackson, David B.
    Soldatos, Theodoros G.
    CANCERS, 2020, 12 (04)
  • [7] Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma
    Longoria, Teresa C.
    Tewari, Krishnansu S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (10) : 1247 - 1253
  • [8] Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials
    Wang, Manni
    Ma, Xuelei
    Guo, Linghong
    Xia, Fan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2851 - 2860
  • [9] A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma
    Hanna, Kirollos S.
    PHARMACOTHERAPY, 2016, 36 (11): : E183 - E188
  • [10] Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review
    Rizzetto, Giulio
    De Simoni, Edoardo
    Molinelli, Elisa
    Offidani, Annamaria
    Simonetti, Oriana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)